Ai says no to Aoxing
This article was originally published in Scrip
Executive Summary
Mr. Bob Yunjun Ai has resigned as Chief Financial Officer of Aoxing Pharmaceutical, the US-incorporated specialty pharma company with its operations in China, specialising in research, development, manufacturing and distribution of a variety of narcotics and pain-management products, to pursue other business interests. The company has appointed Mr. Guoan Zhang, former Senior Vice President of Finance, as acting Chief Financial. The Company also appointed Ms Guirong Zhou as Vice President of R&D to lead the R&D function.